BEAM logo

Beam Therapeutics (BEAM) Revenue

Annual Revenue

$377.71 M
+$316.79 M+520.01%

31 December 2023

BEAM Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Revenue

$14.27 M
+$2.50 M+21.21%

30 September 2024

BEAM Quarterly Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Revenue

$349.64 M
-$2.92 M-0.83%

30 September 2024

BEAM TTM Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BEAM Revenue Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+520.0%-17.0%+328.7%
3 y3 years+10000.0%+1770.1%+10000.0%
5 y5 years-+10000.0%+10000.0%

BEAM Revenue High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high>+9999.0%-95.5%+1770.1%-7.4%>+9999.0%
5 y5 yearsat high>+9999.0%-95.5%>+9999.0%-7.4%>+9999.0%
alltimeall timeat high>+9999.0%-95.5%>+9999.0%-7.4%>+9999.0%

Beam Therapeutics Revenue History

DateAnnualQuarterlyTTM
Sept 2024
-
$14.27 M(+21.2%)
$349.64 M(-0.8%)
June 2024
-
$11.77 M(+58.9%)
$352.57 M(-2.3%)
Mar 2024
-
$7.41 M(-97.7%)
$360.91 M(-4.4%)
Dec 2023
$377.71 M(+520.0%)
$316.19 M(+1739.1%)
$377.71 M(+363.1%)
Sept 2023
-
$17.19 M(-14.5%)
$81.55 M(+1.7%)
June 2023
-
$20.12 M(-16.9%)
$80.16 M(+4.5%)
Mar 2023
-
$24.21 M(+20.8%)
$76.70 M(+25.9%)
Dec 2022
$60.92 M(+17.5%)
$20.04 M(+26.8%)
$60.92 M(-33.7%)
Sept 2022
-
$15.80 M(-5.1%)
$91.95 M(+19.5%)
June 2022
-
$16.65 M(+97.5%)
$76.92 M(+27.6%)
Mar 2022
-
$8.43 M(-83.5%)
$60.27 M(+16.3%)
DateAnnualQuarterlyTTM
Dec 2021
$51.84 M(>+9900.0%)
$51.07 M(+6593.2%)
$51.84 M(+6538.2%)
Sept 2021
-
$763.00 K(>+9900.0%)
$781.00 K(+3154.2%)
June 2021
-
$6000.00(0.0%)
$24.00 K(0.0%)
Mar 2021
-
$6000.00(0.0%)
$24.00 K(0.0%)
Dec 2020
$24.00 K(+33.3%)
$6000.00(0.0%)
$24.00 K(0.0%)
Sept 2020
-
$6000.00(0.0%)
$24.00 K(0.0%)
June 2020
-
$6000.00(0.0%)
$24.00 K(0.0%)
Mar 2020
-
$6000.00(0.0%)
$24.00 K(+33.3%)
Dec 2019
$18.00 K
$6000.00(0.0%)
$18.00 K(+50.0%)
Sept 2019
-
$6000.00(0.0%)
$12.00 K(+100.0%)
June 2019
-
$6000.00
$6000.00

FAQ

  • What is Beam Therapeutics annual revenue?
  • What is the all time high annual revenue for Beam Therapeutics?
  • What is Beam Therapeutics annual revenue year-on-year change?
  • What is Beam Therapeutics quarterly revenue?
  • What is the all time high quarterly revenue for Beam Therapeutics?
  • What is Beam Therapeutics quarterly revenue year-on-year change?
  • What is Beam Therapeutics TTM revenue?
  • What is the all time high TTM revenue for Beam Therapeutics?
  • What is Beam Therapeutics TTM revenue year-on-year change?

What is Beam Therapeutics annual revenue?

The current annual revenue of BEAM is $377.71 M

What is the all time high annual revenue for Beam Therapeutics?

Beam Therapeutics all-time high annual revenue is $377.71 M

What is Beam Therapeutics annual revenue year-on-year change?

Over the past year, BEAM annual revenue has changed by +$316.79 M (+520.01%)

What is Beam Therapeutics quarterly revenue?

The current quarterly revenue of BEAM is $14.27 M

What is the all time high quarterly revenue for Beam Therapeutics?

Beam Therapeutics all-time high quarterly revenue is $316.19 M

What is Beam Therapeutics quarterly revenue year-on-year change?

Over the past year, BEAM quarterly revenue has changed by -$2.92 M (-17.01%)

What is Beam Therapeutics TTM revenue?

The current TTM revenue of BEAM is $349.64 M

What is the all time high TTM revenue for Beam Therapeutics?

Beam Therapeutics all-time high TTM revenue is $377.71 M

What is Beam Therapeutics TTM revenue year-on-year change?

Over the past year, BEAM TTM revenue has changed by +$268.09 M (+328.73%)